2011-12-21 - BioTime Signs Agreement with USCN Life Science to Source Antibody-Based Products

BioTime, Inc. (NYSE Amex: BTX) today announced agreements with USCN Life Science, Inc. (USCN) of Wuhan, China, granting BioTime an option to license USCN's antibody-producing cell lines.